Clinical trials: Healthy Active Females

Postmenopausal Osteoporosis

Safety, Tolerability, Pharmacokinetic and Pharmacodynamic Effect of PTH134 at Increasing Doses in Healthy Postmenopausal Subjects

• Completed
• Age: 40 to 70 years
• Phase 1

This study is designed to investigate the safety and tolerability of PTH134 in healthy subjects and to assess the exposure from PTH134.

Trial name

NCT00676312

Testing

PTH134

Where

Switzerland

Volunteers

32 people

Sponsor

Novartis